Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Gastrointestinal neoplasms malignant NEC
ADR ID BADD_A01783
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.13      Gastrointestinal neoplasms malignant and unspecified
16.13.04      Gastrointestinal neoplasms malignant NEC
Description Not Available
MedDRA Code 10017992
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01834Prednisone--
BADD_D01835Pregabalin--
BADD_D01898Rabeprazole--
BADD_D01913Ranitidine0.002301%
BADD_D01922Regorafenib0.003358%
BADD_D01951Risperidone0.000121%
BADD_D01954Rivaroxaban0.000475%
BADD_D01966Ropinirole--
BADD_D02029Sitagliptin0.000053%
BADD_D02058Sorafenib0.000392%
BADD_D02100Sunitinib0.006984%
BADD_D02105Tacrolimus0.000297%
BADD_D02165Teriflunomide0.000362%
BADD_D02241Tolcapone--
BADD_D02257Trametinib0.000336%
BADD_D02331Valsartan0.000212%
BADD_D02345Venetoclax0.000168%
BADD_D02352Verteporfin--
BADD_D02365Vismodegib0.000112%
BADD_D02373Warfarin0.000042%
BADD_D02375Water--
BADD_D02392Zoledronic acid--
BADD_D02393Zolmitriptan--
BADD_D02412Octreotide0.000186%
BADD_D02464Fingolimod0.001688%
BADD_D02473Sodium chloride--
BADD_D02526Larotrectinib0.000112%
BADD_D02568Lutetium oxodotreotide lu-177-
BADD_D02591Ripretinib0.000112%
The 2th Page    First    Pre   2    Total 2 Pages